Yes. Rifaximin is frequently prescribed for the short-term treatment of traveler’s diarrhoea caused by non-invasive E. coli. Carry the medication in its original packaging, and follow the prescribed 3-day course. Remember that some countries require a prescription for import, so obtain a copy of the prescription before you travel.
Take the missed tablet as soon as you remember, unless it is almost time for the next scheduled dose. In that case, skip the missed tablet and continue with the regular dosing schedule-do not double the dose.
Rifaximin is not typically included in routine workplace or anti-doping screens because it has negligible systemic absorption and is not a controlled substance. However, specific tests can be ordered if there is a clinical reason.
In the UK, the common brand Xifaxan 200 mg tablets are white, round, and bearing the imprint “X 200”. The 400 mg tablets are bicolored (white and blue) with the imprint “X 400”. Generic versions may vary in color and imprint but will always list the strength and ingredient on the label.
No strict dietary restrictions are required. The medication may be taken with or without food. However, consuming very high-fat meals could modestly delay gastric emptying, which does not affect overall efficacy.
Rifaximin is classified as Pregnancy Category B2 in the UK, indicating that animal studies have not shown risk but human data are limited. It should be used only if the potential benefit outweighs any possible risk, and always under medical supervision.
No. Rifaximin is not indicated for the treatment of C. difficile colitis and may, in rare cases, predispose to this infection by altering normal gut flora. Standard agents such as vancomycin or fidaxomicin remain first-line therapies.
Both strengths contain the same active ingredient and work by the same mechanism. The 400 mg tablet provides a higher dose per pill, allowing certain regimens (e.g., twice-daily dosing) to be delivered with fewer tablets compared to the 200 mg formulation.
Rifaximin remains stable for up to 24 months when stored at room temperature, protected from moisture and heat. Once the blister pack is opened, keep the tablets in the original container with the lid tightly closed and avoid exposure to humidity.
Rifaximin is a broad-spectrum antibiotic that belongs to the rifamycin class. It is formulated as oral pills (available in 200 mg and 400 mg strengths) and is used primarily to modify the bacterial environment of the gastrointestinal tract. In the United Kingdom the Medicine and Healthcare products Regulatory Agency (MHRA) classifies rifaximin as a prescription-only medicine (POM). It is marketed under several brand names, the most common being Xifaxan.
Note: These approvals are specific to the UK Regulatory Authority (MHRA). Availability and approved uses may differ in other jurisdictions.
These symptoms are usually transient and resolve without intervention. Maintaining adequate hydration and a balanced diet can help mitigate discomfort.
Practical advice: Patients should disclose all current medications, over-the-counter products, and herbal supplements to their prescriber before initiating rifaximin.
Only the 200 mg and 400 mg tablet strengths are commercially stocked; the exact tablet count per dose should be confirmed by the prescribing clinician.
This article provides educational information about rifaximin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
